These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15251744)

  • 21. Graves' disease occurring after surgery of a multinodular goiter: a case report.
    Heinzel A; Müller HW; Poeppel TD; Engers R; Hautzel H
    Exp Clin Endocrinol Diabetes; 2009 Feb; 117(2):95-7. PubMed ID: 18563680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of hyperthyroidism.
    Quérat C; Germain N; Dumollard JM; Estour B; Peoc'h M; Prades JM
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Apr; 132(2):63-6. PubMed ID: 25592327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report.
    Yürekli Y; Cengiz A; Güney E
    Mol Imaging Radionucl Ther; 2015 Oct; 24(3):135-7. PubMed ID: 27529890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
    Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
    J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment of children Graves' disease with huge goiter-a case report and literature review.
    Li Y; Cui X; Yang Y; Liang Y; Chai F; Sun YC; Shao C; Mo H; Yin S; Yang Z; Zhang F
    Gland Surg; 2020 Apr; 9(2):467-473. PubMed ID: 32420276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.
    Díez JJ
    Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An uncommon case of Marine-Lenhart syndrome.
    Giuffrida G; Giovinazzo S; Certo R; Vicchio TM; Baldari S; Campennì A; Ruggeri RM
    Arq Bras Endocrinol Metabol; 2014 Jun; 58(4):398-401. PubMed ID: 24936736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
    Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapses of hyperthyroidism in patients treated with radioiodine for nodular toxic goiter: relation to thyroid autoimmunity.
    Custro N; Ganci A; Scafidi V
    J Endocrinol Invest; 2003 Feb; 26(2):106-10. PubMed ID: 12739735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental thyroid carcinoma in patients with Graves' disease.
    Phitayakorn R; McHenry CR
    Am J Surg; 2008 Mar; 195(3):292-7; discussion 297. PubMed ID: 18206132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
    Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
    Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radioiodine treatment of benign thyroid diseases].
    Konrády A
    Orv Hetil; 2006 Sep; 147(37):1783-9. PubMed ID: 17131798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total thyroidectomy: is morbidity higher for Graves' disease than nontoxic goiter?
    Welch KC; McHenry CR
    J Surg Res; 2011 Sep; 170(1):96-9. PubMed ID: 21550063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperthyroidism with thyroid cancer: more common than expected?
    Aksoy SÖ; Sevinç Aİ; Durak MG
    Ann Ital Chir; 2020; 91():16-22. PubMed ID: 32180570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.